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IntrOductIOn
Bacterial Vaginosis (BV) is the most common cause of vaginal 
discharge and infection in women of child bearing age in the world 
[1]. BV is a change in the normal flora of the vagina, which leads 
to reduced hydrogen peroxidase-producing lactobacilli and an 
overgrowth of anaerobic bacteria. The aetiology of BV is not well-
understood, but related to the replacement of Lactobacillus bacteria 
in the vagina with other bacteria such as Gardnerella vaginalis, 
Ureaplasma, Mycoplasma hominis, Mobiluncus, Prevotella, and 
other bacteria [1,2].
Normally, lactic acid, hydrogen peroxide and bacteriocins are 
produced by lactobacilli and help to keep the acidic vaginal pH and 
protect against infection caused by microorganisms [3]. Bacteria 
responsible for BV produce enzymes that destroy protective layer 
(gel layer) of the epithelium of vagina and cervix [3]. In addition, 
these anaerobes produce inflammatory proteins related to preterm 
delivery, pelvic inflammatory disease, endometritis, gonorrhea, 
post gynaecologic surgery infection and Chlamydia throchomatis 
[1,4,5].
The most common symptom of BV is vaginal discharge with mal-
odor [5], which stops sexual life and influences activity in society [6]. 
Vaginal exam shows a gray, thin and homogeneous discharge that 
covers the vaginal wall [7].
The treatment basis of BV is the use of topical or systemic 
antibiotics like metronidazole and clindamycin effecting on anaerobic 
organisms but the normal vaginal lactobacilli unaffected [8]. In 
addition, acidification of the vagina helps lactobacilli colonization 
and prevents anaerobic growth [9]. Moreover, the use of antiseptics 
and probiotics are effective in the treatment of BV [8].
 
Metronidazole is a drug with an excellent performance against the 
anaerobe and a weak one against lactobacilli, and it is also the 
first choice for treatment of BV [10]. The use of metronidazole may 
cause side effects such as dark coloured urine, drowsiness, metallic 
taste in mouth, dizziness, nausea, transient neutropaenia, alcohol-
disulfiram reaction, peripheral neuropathy, diarrhea, vomiting and 
rarely pancreatitis (in the form of oral and vaginal). In addition, in rare 
cases there may be an allergy to metronidazole. In some cases, 
resistance to metronidazole can be observed [11-13].
In recent years, due to great interest of people in herbal medicines 
and side effects of chemical drugs, the use of herbal drugs like 
Communis Myrtus and Berberis vulgaris has increased.
Myrtus communis L is a small tree shrub of the family Myrtace in 
which the medicinal part are the leaves. The essential oil in leaves 
consists of tannins, flavonoids, vitamin C without cardiac glycosides 
and alkaloids. There are some believes that Communis Myrtus L 
has astringent, anti-diarrhea and hair strengthening and growing 
effects. This herb was used topically to treat herpes. The plant 
extract can inhibit the growth of bacteria like Staphylococcus 
aureus, Pseudomonas aeruginosa, and Escherichia coli [14].
Berberis vulgaris is the plant of the family Berberidaceae which has 
been used as an appetizer and anti-inflammatory agent in past. In 
addition, antibacterial effect of Berberis vulgaris has been proved 
[15].
Recently, people tend to use traditional therapy; on the other hand, 
there are some problems in treatment of BV. Considering the 
properties of Berberis vulgaris and Myrtus communis, the present 
study aimed to compare the efficacy of metronidazole vaginal gel 
with combination of both of the mentioned plants, in treatment and 
recurrence of BV. 
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ABStrAct
Introduction: There is a growing tendency towards herbal 
medicines for treatment of vaginitis. Antibacterial and antifungal 
effects of Myrtus communis L and Berberis vulgaris have been 
demonstrated invitro and invivo. 
Aim: This study aimed to compare the therapeutic effects of 
the vaginal gel of Berberis vulgaris 5% (in metronidazole base) 
and Myrtus communis L 2% (in metronidazole base) with only 
metronidazole vaginal gel 0.75% on bacterial vaginosis.
Materials and Methods: This study was a randomized clinical 
trial research on 120 married women aged 18-40 years affected 
by bacterial vaginosis attended for treatment to gynaecology 
clinic of Hajar Hospital (Shahrekord, Iran). They were randomly 
divided into three groups of 40 participants. Diagnostic criteria 
were Amsel's criteria. Myrtus communis L, Berberis vulgaris 
vaginal gel or metronidazole vaginal gel for five-night usage 
were prescribed to each group, and after 7 days therapeutic 
effects were assessed. Data analysis was performed using 
ANOVA and Chi-square tests.
results: A statistically significant difference was observed with 
regard to treatment response among the study groups (p<0.001), 
with Myrtus communis L and Berberis vulgaris groups having a 
better response than metronidazole gel alone. Moreover, there 
was no significant difference between Myrtus communis L and 
Berberis vulgaris groups (p= 0.18). The patients in groups of 
Myrtus communis L or Berberis vulgaris in metronidazole base 
did not experience any relapse, but in metronidazole group, 
30% of patients experienced relapse during three weeks follow 
up.
conclusion: Findings of the study showed that treatment with 
a combination of Myrtus communis L or Berberis vulgaris in 
metronidazole base improve the efficacy of bacterial vaginosis 
therapy.
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Groups/Variable Metron-
idazole 
alone
Berberis 
Vulgaris in 
Metron-
idazole 
Base
Myrtus 
communis 
in Metron-
idazole 
Base
p-value
Age/ Years (Mean± SD) 32.48±6.38 32.75±6.96 33.4±4.65 0.86
Age at Menarche/ Years 
(Mean± SD)
13.45±1.13 13.62±1.05 13.7±1.74 0.56
Age at Marriage/ Years 
(Mean± SD)
20.25±4.21 19.02±3.73 18.85±2.98 0.37
Gravida (Mean± SD 2.18±1.31 2.32±1.94 2.50±1.24 0.36
Parity (Mean± SD) 2.05±1.30 1.92±1.80 2.15±1.09 0.14
Number of Abortion (Mean± 
SD)
0.25±0.54 0.32±0.65 0.35±0.66 0.81
Job employed 4 5 5 0.4
Unemployed 36 35 35
Education 
Level
Illiterate 2 2 2 0.35
Diploma 19 19 19
Diploma and 
above
19 19 19
[table/Fig-1]: Demographic characteristic of patients in the study groups. 
MAterIAlS And MethOdS
This study was conducted after approval of the study protocol by 
Ethics Committee of Shahrekord University of Medical Sciences 
(ethical no. 92-6-33). The study was a randomized double-blind 
clinical trial in which the patients and the physician were unaware of 
medication. The study was done on 120 married women affected 
with BV referred to Hajar clinic of Shahrekord from March to 
December 2013.
The diagnosis of BV was based on Gram staining and Amsel's 
criteria. Having three positive criterion of four Amsel's criteria were 
considered as BV [16]:
1. Thin homogeneous white or gray vaginal discharge. 
2. Positive Whiff test. 
3. More than 20% of clue cells in the wet smear of vagina. 
4. Vaginal pH more than 4.5.
Inclusion criteria were diagnosis of BV based on Amsel's criteria 
and married women aged between 18-40 years with willingness to 
participate in the study. Exclusion criteria were use of systemic or 
local antibiotics in the past two weeks, post-menopausal women, 
pregnancy, virgin, history of hysterectomy, spotting, pelvic infection, 
sperm in  smear, associated diseases such as diabetes and  immune 
deficiency and sensitivity to  Berberis vulgaris or Myrtus communis 
diagnosed by its symptoms as allergies, itching, redness, etc.
The researcher explained the goals and methods of the study to 
the patients and they signed an informed consent form. All patients 
could withdraw from the study at any time and for any reason. 
Randomization was done using the coded papers. The patients in 
each group were matched in terms of age, education, parity and 
contraceptive methods (40 in each group).
The study was conducted in agreement with the Declaration of 
Helsinki and its subsequent revisions and in accordance with local 
Institutional Review Board recommendations.
Patients in different groups were treated for 5 nights in the following 
way:
Group a: Vaginal gel of Myrtus communis 2% [17] in metronidazole 
base, Group B Vaginal gel of Berberis vulgaris 5% in metronidazole 
base, and Group C: Vaginal gel of Metronidazole 0.75% alone.
They were instructed how to take the medication and follow up 
visits. In addition, they were instructed to prohibit from intercourse, 
vaginal washing, and to avoid from other vaginal medication at 
the night they took the medication. Seven days after the 5-day 
treatment, patients were re-evaluated for the therapeutic response. 
Lack or remaining of only one of the Amsel’s criteria was considered 
as an effective treatment [18]. The patients who have not recovered 
after the treatment period were treated using oral metronidazole. 
In addition, within three weeks after the treatment, patients were 
evaluated in terms of recurrence of BV. Finally, their satisfaction on 
taking these medications was evaluated.
extraction and preparation of vaginal gel: The leaves of Myrtus 
communis from the area of Lordegan (South West of Iran) and fruit of 
Berberis vulgaris from Mashhad (North East of Iran) were collected. 
The extraction method was percolation with ethanol 70%. The 
prepared extract of Myrtus communis and Berberis vulgaris were 
added to metronidazole as the basis in concentration of 2% and 
5% respectively by a pharmacologist. Prepared gels were filled in 
special tubes with the same shape and certain code.
The  antioxidant properties of Berberis vulgaris and Myrtus 
communis extracts were determined by DPPH (Di Phenyl Picryl 
Hydrazyl) method which was used by Rabiei and colleagues [19].
Invitro antibacterial activity of extracts: In order to determine 
the minimum inhibitory concentration (MIC) of each extract, 20 mg 
of each extract was dissolved in 1ml saline normal, then different 
dilutions in saline normal (1.25, 2.5, 5, 10, and 20) were prepared. 
In the next step, a loop of bacterial suspension were added into 
the Butylated hydroxytoluene (BHT) and incubated for 4 hours in 
37°C. Finally, each dilution was inoculated in sterile condition in 
methylene blue agar medium for 24 hours in 37°C and evaluated 
for antibacterial activity.
StAtIStIcAl AnAlySIS 
Data were analysed by SPSS software (version 11.5; SPSS, 
Chicago, IL) using Tukey, Chi-Square test, and ANOVA, and p-value 
less than 0.05 was considered as significant. 
reSultS
In this study, 120 married women with average age of 32.88±6.04 
years (19-40 years) were participated. According to the information, 
90.5% of participants previously were treated (27.5% traditional 
treatment) and 5% of them had a history of hospitalization for BV. 
Chi-square tests showed no significant differences among groups 
in terms of age, age at menarche, age at marriage, education level, 
employment status, method of contraception, parity, number of 
births, and abortions (p>0.05). Moreover, the study groups were 
matched in terms of history and frequency of vaginal infection, 
medical and traditional treatment, and frequency of hospitalization 
[Table/Fig-1]. Based on Chi-square test, clinical symptoms of BV at 
baseline were similar amongst the study groups [Table/Fig-2].
The ANOVA test showed a significant difference among the groups 
in terms of recovery (cure) (p<0.01). Regarding the Tukey test, there 
was a statistically significant difference between Myrtus communis 
group and metronidazole gel alone (p<0.001) in terms of recovery. 
However, this difference was also seen in metronidazole alone and 
Berberis vulgaris groups (p<0.001), but there was no significant 
difference between the Berberis vulgaris and Myrtus communis (p 
=0.18) [Table/Fig-3]. 
Generally, results of the study showed that vaginal gel consists of 
extracts of Myrtus communis or Berberis vulgaris in metronidazole 
base were more effective than metronidazole gel alone on BV. 
Furthermore, all patients taking herbal combination had no 
recurrence three weeks after the treatment period while in 
metronidazole alone 30% of patients had recurrence. 
With regard to the invitro section of the study, MIC for Myrtus 
communis and Berberis vulgaris were determined as 2.5 mg/ml and 
20 mg/ml respectively.
In addition, by DPPH method, the amounts of phenol were 91.08 
mg/g, flavonoid 62.70 mg/g, and flavonol 34.38 mg and antioxidant 
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Groups Cured p-value 
(cured)
uncured
frequency percent 
(%)
frequency percent 
(%)
Metronidazole Alone 17 42.5
p<0.001
23 57.5
Berberis Vulgaris in 
Metronidazole Base 
4 10 36 90
Myrtus communis in 
Metronidazole Base 
2 5 38 95
Groups/
Variable
Metronidazole 
alone
Berberis Vulgaris 
in Metronidazole 
Base
Berberis Vulgaris 
in Metronidazole 
Base
p 
value
frequency % frequency % frequency %
Burning 
Vagina
Yes 27 67.5 21 52.5 24 60 0.39
No 13 32.5 19 47.5 16 40
Itching Yes 25 62.5 20 50 24 60 0.48
No 15 37.5 20 50 16 40
Redness Yes 14 35 18 45 12 30 0.36
No 26 65 22 55 28 70
Dyspa-
reunia
Yes 16 40 18 45 25 62.5 0.10
No 24 60 22 55 15 37.5
Ague Yes 4 10 9 22.5 7 17.5 0.32
No 36 90 31 77.5 33 82.5
Dysuria Yes 14 35 16 35 17 42.5 0.78
No 26 65 24 65 23 57.5
Dysme-
norrhea
Yes 18 45 19 47.5 20 50 0.90
No 22 55 21 52.5 20 50
[table/Fig-3]: Comparison recovery rate among the study groups.
[table/Fig-2]: Comparison of different groups in baseline symptoms of bacterial 
vaginosis. There was no significant difference between the study groups (p>0.05).
capacity 77.1Ug/ml in Myrtus communis extract.  Also in Berberis 
vulgaris extract, 157 mg/g phenol, 12.2 mg/g flavonoid, and 25 mg/g 
flavonol, and antioxidant capacity 139.6Ug/ml were measured.
dIScuSSIOn
The result of present study showed that vaginal gel consist of 
extracts of Myrtus communis or Berberis vulgaris in metronidazole 
base were more effective than metronidazole alone on BV without 
any serious side effect and relapse. In addition, recurrence rate in 
metronidazole group was 30% similar to result of study of Sobel and 
colleague [20].
This  study is the first study on human which determine the 
therapeutic effect of  Myrtus communis and Berberis vulgaris in 
metronidazole base in comparison with metronidazole vaginal gel 
alone on BV, so there is no similar human study confirming these 
results, but some invitro studies showed the antimicrobial effect of 
Berberis vulgaris and Myrtus communis [21,22].
Isoquanils like Berberin, Berbamine and Palmatine are some of the 
active ingredient of Berberis vulgaris [23] and anti-inflammatory, 
anti-histaminic and anti-microbial effects of Berberis vulgaris on 
BV may be due to these ingredients. Berberin is one of the most 
important ingredients in Berberis vulgaris with antibacterial and 
antifungal properties. Studies have shown that this substance has 
inhibitory effect on Candida albicans growth, Trichomonas vaginalis, 
and Staphylococcus aureus [24]. Han and colleagues in their study 
showed that the combination of amphotericin B and berberin can be 
reduced up to 75% of required dose of amphotericin B in treatment 
of candidiasis [25]. Soffarr et al., found that berberin has inhibitory 
effect on growth of Trichomonas vaginalis similar to metronidazole 
[26].
According to finding of study carring out by Oh and collegue, 
berberin has a potent inhibitory activity against sortase A and 
sortase B. Inhibition of these enzymes significantly decrease 
virulence and pathogenesis of Staphylococcus aureus and propose 
as antibacterial mechanism of berberin [27]. Kupeli and colleagues 
proved anti-nociceptive and anti-inflammatory effects of berberin 
[28] which probably is related to prostaglandin E2 and reduction of 
cyclooxygenase [29].
Shamsa and colleagues in their study showed that the fruit of 
Berberis vulgaris has anti-histaminic property and contains vitamin 
C and acidic compounds [30], therefore, these can remove  some 
symptoms of vaginosis [31]. Vitamin C by decreasing acidity of the 
vagina inhibits the bacteria growth in acidic environment. In addition, 
bacteria such as lactobacilli have tendency to grow in acidotic 
condition of vagina and actually undesired anaerobes strongly are 
inhibited by acidotic components of vitamin C [32].
The results of the study showed that Myrtus communis in 
metronidazole base was the most effective combination in the 
treatment of BV among study groups. In addition, according to 
finding of the invitro section of the study, Myrtus communis extract 
was more effective than Berberis vulgaris extract in lower dilutions.
Polyphenols, myrtucommulone (MC), semimyrtucommulone 
(S-MC), 1, 8-cineole, α-pinene, myrtenyl acetate, limonene, linalool, 
and α-terpinolene are the most important ingredients in Myrtus 
communis with biological activity. Clinical and experimental studies 
suggest that Myrtus communis possesses a broader spectrum 
of pharmacological and therapeutic effects such as antioxidative, 
anticancer, antidiabetic, antiviral, antibacterial, antifungal, 
hepatoprotective and neuroprotective activity [33,34].
Houshmand et al., showed that the extract of Myrtus communis in 
different concentrations have antibacterial effects against aerobic 
and anaerobic bacteria [35]. The antibacterial activity of Myrtus 
communis is due to the increase of oxygen free radicals and lipid 
peroxidation, which can destroy the wall of microorganisms [36]. 
Myrtus communis, has anti-inflammatory and anti-nociceptive 
effects [37,38]. These properties explain the therapeutic effects of 
Myrtus communis on BV in comparison with metronidazole alone.
cOncluSIOn
Regarding the findings of the study, vaginal gel consist of Myrtus 
communis or Berberis vulgaris extract in metronidazole base is 
more effective than metronidazole gel alone and could be used as 
alternative option in medication resistance patients or patients with 
trend to herbal medicine. Since Myrtus communis and Berberis 
vulgaris have antibacterial, antifungal, and anti-inflammatory effects, 
it seems necessary to conduct more studies to evaluate efficacy of 
these plants in treatment of bacterial and non- bacterial vaginitis.
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